Autoimmune Treatment News - Latest Updates & Headlines
Celltrion launches autoimmune disease treatment in US
Seoul, March 13: Celltrion, a major South Korean biopharmaceutical firm, on Thursday said it has launched its biosimilar product for Stelara, an autoimmune disease treatment, in the United States.
Celltrion's autoimmune disease treatment gets approval in Europe
Seoul, Feb 24: Celltrion, a major South Korean biopharmaceutical firm, on Monday said its new biosimilar for an autoimmune disease treatment has obtained approval from the European Commission (EC).